rs111274092
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_018668.5(VPS33B):c.240-13_240-12delTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0856 in 1,607,042 control chromosomes in the GnomAD database, including 5,909 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.094 ( 743 hom., cov: 32)
Exomes 𝑓: 0.085 ( 5166 hom. )
Consequence
VPS33B
NM_018668.5 intron
NM_018668.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.492
Publications
1 publications found
Genes affected
VPS33B (HGNC:12712): (VPS33B late endosome and lysosome associated) Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene is a member of the Sec-1 domain family, and encodes the human ortholog of rat Vps33b which is homologous to the yeast class C Vps33 protein. The mammalian class C vacuolar protein sorting proteins are predominantly associated with late endosomes/lysosomes, and like their yeast counterparts, may mediate vesicle trafficking steps in the endosome/lysosome pathway. Mutations in this gene are associated with arthrogryposis-renal dysfunction-cholestasis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 15-91014444-GAA-G is Benign according to our data. Variant chr15-91014444-GAA-G is described in ClinVar as [Likely_benign]. Clinvar id is 261045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS33B | NM_018668.5 | c.240-13_240-12delTT | intron_variant | Intron 3 of 22 | ENST00000333371.8 | NP_061138.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS33B | ENST00000333371.8 | c.240-13_240-12delTT | intron_variant | Intron 3 of 22 | 1 | NM_018668.5 | ENSP00000327650.4 | |||
ENSG00000284946 | ENST00000643536.1 | n.240-13_240-12delTT | intron_variant | Intron 3 of 34 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes AF: 0.0941 AC: 14228AN: 151204Hom.: 742 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14228
AN:
151204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0855 AC: 21280AN: 248754 AF XY: 0.0891 show subpopulations
GnomAD2 exomes
AF:
AC:
21280
AN:
248754
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0847 AC: 123336AN: 1455720Hom.: 5166 AF XY: 0.0863 AC XY: 62494AN XY: 724498 show subpopulations
GnomAD4 exome
AF:
AC:
123336
AN:
1455720
Hom.:
AF XY:
AC XY:
62494
AN XY:
724498
show subpopulations
African (AFR)
AF:
AC:
4466
AN:
33090
American (AMR)
AF:
AC:
1897
AN:
43716
Ashkenazi Jewish (ASJ)
AF:
AC:
2979
AN:
25986
East Asian (EAS)
AF:
AC:
646
AN:
39670
South Asian (SAS)
AF:
AC:
11333
AN:
85782
European-Finnish (FIN)
AF:
AC:
4260
AN:
53284
Middle Eastern (MID)
AF:
AC:
772
AN:
5732
European-Non Finnish (NFE)
AF:
AC:
91834
AN:
1108332
Other (OTH)
AF:
AC:
5149
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
5864
11727
17591
23454
29318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0941 AC: 14245AN: 151322Hom.: 743 Cov.: 32 AF XY: 0.0938 AC XY: 6931AN XY: 73892 show subpopulations
GnomAD4 genome
AF:
AC:
14245
AN:
151322
Hom.:
Cov.:
32
AF XY:
AC XY:
6931
AN XY:
73892
show subpopulations
African (AFR)
AF:
AC:
5251
AN:
41262
American (AMR)
AF:
AC:
942
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
AC:
402
AN:
3466
East Asian (EAS)
AF:
AC:
109
AN:
5172
South Asian (SAS)
AF:
AC:
636
AN:
4794
European-Finnish (FIN)
AF:
AC:
788
AN:
10284
Middle Eastern (MID)
AF:
AC:
31
AN:
292
European-Non Finnish (NFE)
AF:
AC:
5737
AN:
67810
Other (OTH)
AF:
AC:
197
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
599
1198
1797
2396
2995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Feb 09, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Oct 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This variant is associated with the following publications: (PMID: 16896922) -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis with renal dysfunction and cholestasis syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.